Thomas Templeman - 30 Sep 2022 Form 4/A - Amendment Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Chief Technology Officer
Signature
/s/ Gregory Weinhoff, attorney-in-fact
Issuer symbol
CNTA
Transactions as of
30 Sep 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
23 Nov 2022, 16:06:22 UTC
Date Of Original Report
04 Oct 2022
Previous filing
06 Jul 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CNTA Ordinary Shares 140,250 30 Sep 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 The transactions previously reported on the Form 4 filed on October 4, 2022 were canceled in their entirety before settlement by the broker without instruction from the Issuer or Reporting Person.